APPLICATIONS PUBLISHED 22 MAY 2002
Published: 1-Dec-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Implantable drug delivery catheter system with capillary interface
Thomas Jefferson University 1206243*
Aqueous pharmaceutical compsn containing moxifloxacin or salts thereof
Bayer 1206244*
Phopholipid gel
Merckle 1206245*
Floating pharmaceutical compsns comprising an active phase and a non-active phase
Galenix Developpement 1206247*
Controlled-release sedative-hypnotic compsns and methods related thereto
Neurocrine Biosciences 1206248*
Hydrodynamically balancing oral drug delivery system
Ranbaxy Laboratories 1206249*
Pharmaceutical formulations with different release times
Elan Corporation 1206250*
Amplification of folate-mediated targeting to tumour cells using nanoparticles
Biotech Australia 1206251*
Pharmaceutical formulation containing nanosol
LTS Lohmann Therapie-Systeme 12062523*
Drug releasing biodegradable fibre implant
Board of Regents of the University of Texas System 1206254*
Compoundss obtained from Salvia species having antiviral activity
Georgetown University 1206255*
Combination therapy using pentafluorobenzene sulphonamide and platin compound
Tularik 1206256*
Use of amino-acids for making medicines for treating to insulin-resistance
Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique 1206257*
Compns containing esters for treating parasitic infestations of organisms
Lovegrove Research Ltd 1206258*
Use of substance P antagonists for the treatment of adenocarcinoma
Biopolis 1206259*
SRC kinase inhibitor compounds
Merck 1206260*
Pharmaceutical compsns comprising clavulanic acid or derivative thereof for the treatment of behavioural diseases
Revaax Pharmaceuticals 1206261*
NPY antagonists: spiroisoquinolinone derivatives
Bristol-Myers Squibb 1206262*
FT-Raman spectroscopic measurement of omeprazole isomer ratio in a compsn
aaiPharma 1206263*
Compsns and methods for treating opiate intolerance
Cooper, Barrett 1206264*
SRC kinase inhibitor compounds
Merck 1206265*
Formulations for parenteral use of estramustine phosphate and albumin
Pharmacia Italia 1206266*
Medicaments that contain xenogenic oligo- and/or polyribonucleotides
Seinfeld, Hugo 1206267*
Novel compsns for controlled release of a biologically active agent, and the preparations thereof
Bioxid 1206268*
Compsns and methods for the treatment of skin disorders
Girvan, Don 1206269*
Ceramide and chemotherapeutic agents for inducing cell death
Roger Williams Hospital 1206270*
Compsn and method for enhancing wound healing
Deroyal Industries 1206271*
Hybrid polypeptides with enhanced pharmacokinetic properties
Trimeris 1206272*
Peptides that block viral infectivity and methods of use thereof
Tripep 1206273*
Use of interleukin-18 inhibitors to inhibit tumour metastasis
Yeda Research and Development 1206274*
Irrigation solution and method of inhibition of pain and inflammation
Omeros Medical Systems 1206275*
Tissue volume reduction
Ingenito 12066276*
Methods and materials for the treatment of prostatic carcinoma
Zonagen 1206277*
Peptide mixture and vaccine against a chronic viral infection
Eurodiagnostics 1206278*
Method fro treating TNF-receptor type-2-induced diseases
BASF 1206279*
Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same
Dimensional Foods 1206280*
Moxifloxacin formulation containing common salt
Bayer 1206281*
Film forming polymers, methods of use, and devices and applications thereof
Lavipharm 1206282*
Improved cellular uptake of bioactive agents
Aesgen; Shinal, Edward; Petit, Robert 1206283*
Method of delivery of therapeutic agents using a solution of dextrin
ML Laboratories 1206284*
Drug-carrier complexes and methods of use thereof
The General Hospital Corp 1206285*
Administering a gravity segregation dispersion by continuous infusion
Marsden, John Christopher 1206286*
Novel high viscosity embolising compsns
Micro Therapeutics 1206287*
Caroxylic acid amides, their production and use as drugs
Boehringer Ingelheim Pharma 1206446*
Selective inhibitors of the urokinase plasminogene activators
Wilex Biotechnology 1206447*
Novel vitamin D analogues
Leo Pharmaceutical Products 1206448*
Lactam inhibitors of hepatitis C virus NS3 protease
Bristol-Myers Squibb 1206449*
Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
Agouron Pharmaceuticals 1206450*
Cyclopropylindole derivatives
Spirogen 1206451*
Novel method for preparing benzoperhydroisoindole compounds
Aventis Pharma 1206452*
Process for the preparation of 3,5-dichloropyridine
Syngenta 1206453*
Novel integrin alphavbeta3 inhibitors
Merck Patent 1206454*
Alphavbeta3 integrin inhibitors
Merck Patent 1206455*
Biaryl-oxa(thia)zole derivatives and their use as PPARS modulators
Eli Lilly; Ligand Pharmaceuticals 1206457*
Benzoxazine and benzothiazine derivatives and the use thereof as medicaments
Schering 1206458*
Method for reacting an organic compound with a hydroperoxide
BASF 1206459*
Process for epoxidising substituted cyclohexanones
SmithKline Beecham 1206460*
Process for the preparation of a paclitaxel C-4 methyl carbonate analogue
Bristol-Myers Squibb 1206461*
Heterocyclic compounds inhibiting angiogenesis
Gyogyszerkutato Intezet KFT 1206462*
Fatty acid synthase inhibitors
SmithKline Beecham 1206463*
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing same, and methods of using the same
AalPharma 1206466*
N-heterocyclic derivatives as NOS inhibitors
Berlex Laboratories 1206467*
